Who are Perspective Therapeutics, Inc.'s main suppliers?

Perspective Therapeutics, Inc. (CATX) key suppliers include: U-S-DEPARTMENT-OF-ENERGY, COMECER-SPA, Alpha Tau Medical Ltd., DRTSW, Lantheus Holdings, Inc. and 2 more. View the full supplier network at chainsifter.com/chain/CATX.

Who are Perspective Therapeutics, Inc.'s major customers?

Perspective Therapeutics, Inc. (CATX) key customers include: DRTSW, Lantheus Holdings, Inc., TLPPF, GT-MEDICAL-TECHNOLOGIES-INC. View the full customer network at chainsifter.com/chain/CATX.

What sector is Perspective Therapeutics, Inc. in?

Perspective Therapeutics, Inc. (CATX) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Perspective Therapeutics, Inc. Suppliers, Customers & Supply Chain (CATX)

7Suppliers

4Customers

3Debt Items

20Related Chains

Source-Backed Evidence Depth

Perspective Therapeutics, Inc. (CATX) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

15Total relationships

2Distinct source URLs

6High confidence

0.787Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Perspective Therapeutics, Inc. Suppliers

Ticker	Name	Confidence	Evidence
U-S-DEPARTMENT-OF-ENERGY	U-S-DEPARTMENT-OF-ENERGY	92%	In May 2025 and May 2026, we entered into supply agreements with the U.S. Department of Energy (DOE) under which we will purchase Thorium-228 from the DOE between 2025 and 2027.
COMECER-SPA	COMECER-SPA	90%	In 2024, we entered into a Master Equipment and Services Agreement (MESA) and statements of work (SOWs) thereunder with Comecer SpA (Comecer), pursuant to which we agreed to purchase from Comecer man…
DRTS	Alpha Tau Medical Ltd.	72%	Reciprocal relationship from DRTS graph: Reciprocal relationship from CATX graph: Reciprocal relationship from DRTS graph: Reciprocal relationship from CATX graph: Reciprocal relationship from DRTS g…
DRTSW	DRTSW	72%	Reciprocal relationship from DRTSW graph: e term sheets, effective for a 15-year term following the approval to sell our products, Medison will be responsible for performing regulatory submissions, m…
LNTH	Lantheus Holdings, Inc.	72%	Reciprocal relationship from LNTH graph: Reciprocal relationship from CATX graph: Reciprocal relationship from LNTH graph: Reciprocal relationship from CATX graph: Reciprocal relationship from LNTH g…
TLPPF	TLPPF	72%	Reciprocal relationship from TLPPF graph: her strengthens our supply chain, reducing environmental impact while maximizing resource utilization. We recognize that the future of isotope supply lies in…
TLX	Telix Pharmaceuticals Limited	72%	Reciprocal relationship from TLX graph: Reciprocal relationship from CATX graph: Reciprocal relationship from TLX graph: her strengthens our supply chain, reducing environmental impact while maximizi…

Perspective Therapeutics, Inc. Customers

Ticker	Name	Confidence	Evidence
DRTSW	DRTSW	72%	Reciprocal relationship from DRTSW graph: e term sheets, effective for a 15-year term following the approval to sell our products, Medison will be responsible for performing regulatory submissions, m…
LNTH	Lantheus Holdings, Inc.	72%	Reciprocal relationship from LNTH graph: tion and the potential that efforts to extend or secure separate or otherwise adequate payment for radiopharmaceutical diagnostics are unsuccessful. • The ext…
TLPPF	TLPPF	72%	Reciprocal relationship from TLPPF graph: Reciprocal relationship from CATX graph: Reciprocal relationship from TLPPF graph: y ensures a steady and diverse supply of 177 Lu but also allows us to adap…
GT-MEDICAL-TECHNOLOGIES-INC	GT-MEDICAL-TECHNOLOGIES-INC	62%	the Company’s clinical-stage alpha therapy developed for the treatment of neuroendocrine tumors. If good-faith negotiations fail, Lantheus has a one-year right to reenter negotiations if a third part…

Perspective Therapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
CATX-DEBT-8488	Warrants outstanding: 0	90%	xbrl warrant detail from xbrl 2025-12-31.
CATX-DEBT-8489	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2018-06-30.
CATX-DEBT	Debt stack $1.6M	90%	Market cache reports total debt of $1.6M.

Perspective Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Perspective Therapeutics, Inc..

Perspective Therapeutics, Inc. Ownership

Holder	Name	Confidence	Evidence
CATX-OWNER-AVIDITY-PARTNERS-MANAGEMENT-LP	Avidity Partners Management LP	90%	13F overlay lists Avidity Partners Management LP as top holder; 137 tracked holders.

Perspective Therapeutics, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
BSX	Boston Scientific Corporation	100.00	2
AZN	AstraZeneca PLC	100.00	2
ATNM	Actinium Pharmaceuticals, Inc.	100.00	2
DRTSW	Alpha Tau Medical Ltd.	100.00	1	['customer', 'supplier']
CLRB	Cellectar Biosciences, Inc.	100.00	2
BMYMP	Bristol-Myers Squibb Co	100.00	2
DRTS	Alpha Tau Medical Ltd.	100.00	1	['supplier']
JANX	Janux Therapeutics, Inc.	100.00	2
TLPPF	Telix Pharmaceuticals Ltd	100.00	1	['customer', 'supplier']
RADX	Radiopharm Theranostics Limited	100.00	2
SNSE	Sensei Biotherapeutics, Inc.	100.00	2
TLX	Telix Pharmaceuticals Limited	100.00	1	['supplier']
NBTX	Nanobiotix S.A.	100.00	2
LNTH	Lantheus Holdings, Inc.	100.00	1	['customer', 'supplier']
LTGHY	Life Healthcare Group Holdings Limited	50.00	2
COHN	Cohen & Company Inc.	50.00	2
MTNB	Matinas BioPharma Holdings, Inc.	50.00	2
NNBXF	Nanobiotix S.A.	50.00	2
ORANY	ORANGE	50.00	2
BTAIQ	BioXcel Therapeutics, Inc.	50.00	2

Perspective Therapeutics, Inc. Supply Chain